EUVIMEDEUVIMED entdecken
Open Access

The impact of pre‐existing hematologic disorders on morbidity and mortality following heart transplantation: Focus on early graft dysfunction

Matthew R Carey iD, Annamaria Ladanyi, Yonatan Mehlman, Rebecca L Molinsky iD, Andrew Eisenberger, Kevin J Clerkin iD, Justin G Aaron, Koji Takeda, Gabriel T Sayer, Nir Uriel, Ryan T Demmer, Paolo C Colombo und 1 weitere

Clinical Transplantation · 2023

DOI: 10.1111/ctr.14974 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2023. Verfasst von Matthew R Carey und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, NewYork-Presbyterian Columbia University Irving Medical Center, New York, New York, USA. Hauptthemen laut MEDLINE: Primary Graft Dysfunction, Heart Transplantation, Heart Failure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heart transplantation (HT) is the gold standard therapy for advanced heart failure, providing excellent long‐term outcomes. However, postoperative outcomes are limited by bleeding, infections, and primary graft dysfunction (PGD) that contribute to early mortality after HT. HT candidates with pre‐existing hematologic disorders, bleeding, and clotting, may represent a higher risk population. We assessed the short‐ and long‐term outcomes of patients with pre‐existing hematologic disorders undergoing HT. Methods and results Medical records of all adult patients who received HT from January 2010 to December 2019 at our institution were retrospectively reviewed. Hematologic disorders were identified via chart review and adjudicated by a board‐certified hematologist. Inverse probability weighting and multivariable models were used to adjust for potential pretransplant confounders. Four hundred and ninety HT recipients were included, of whom 29 (5.9%) had a hematologic disorder. Hematologic disorders were associated with severe PGD requiring mechanical circulatory support (aOR 3.15 [1.01–9.86]; p = .049), postoperative infections (aOR 2.93 [1.38–6.23]; p = .01), and 3‐year acute cellular rejection (ACR) (≥1R/1B) (aSHR 2.06 [1.09–3.87]; p = .03). There was no difference in in‐hospital mortality (aOR 1.23 [.20–7.58], p = .82) or 3‐year mortality (aHR 1.58 [.49–5.12], p = .44).

Conclusions

Patients with hematologic disorders undergoing HT are at increased risk of severe PGD, postoperative infections, and ACR, while in‐hospital and 3‐year mortality remain unaffected.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary Graft DysfunctionHeart TransplantationHeart FailureAdultHumansRetrospective StudiesMorbidityRisk FactorsPostoperative Complications

Stichwörter der Autor:innen

coagulopathyheart transplantationhematologic disordersprimary graft dysfunction

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine, NewYork-Presbyterian Columbia University Irving Medical Center, New York, New York, USA.
  • Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
  • Division of Hematology/Oncology, Department of Medicine, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York, USA.
  • Division of Infectious Diseases, Department of Medicine, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York, USA.
  • Division of Cardiac, Thoracic & Vascular Surgery, Department of Surgery, NewYork-Presbyterian, Columbia University Irving Medical Center, New York, New York, USA.

ORCID-Profile: Matthew R Carey, Rebecca L Molinsky, Kevin J Clerkin

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Carey, M. R., Ladanyi, A., Mehlman, Y., Molinsky, R. L., Eisenberger, A., Clerkin, K. J., Aaron, J. G., Takeda, K., Sayer, G. T., Uriel, N., Demmer, R. T., Colombo, P. C., & Yuzefpolskaya, M. (2023). The impact of pre‐existing hematologic disorders on morbidity and mortality following heart transplantation: Focus on early graft dysfunction. Clinical Transplantation. https://doi.org/10.1111/ctr.14974

Vancouver

Carey MR, Ladanyi A, Mehlman Y, Molinsky RL, Eisenberger A, Clerkin KJ, et al. The impact of pre‐existing hematologic disorders on morbidity and mortality following heart transplantation: Focus on early graft dysfunction. Clinical Transplantation. 2023. doi:10.1111/ctr.14974

BibTeX
@article{Carey2023,
  author = {Carey, Matthew R and Ladanyi, Annamaria and Mehlman, Yonatan and Molinsky, Rebecca L and Eisenberger, Andrew and Clerkin, Kevin J and Aaron, Justin G and Takeda, Koji and Sayer, Gabriel T and Uriel, Nir and Demmer, Ryan T and Colombo, Paolo C and Yuzefpolskaya, Melana},
  title = {The impact of pre‐existing hematologic disorders on morbidity and mortality following heart transplantation: Focus on early graft dysfunction},
  journal = {Clinical Transplantation},
  year = {2023},
  doi = {10.1111/ctr.14974}
}
Kostenlos starten →